$173.96
Value $49.3B
Agilent TechnologiesvsAbbVie
A and ABBV stock compared: price, dividend, valuation and results, from SEC filings.
+0.55%
$295.03
Value $522B
Agilent Technologies (A) has a market value of $49.3B and AbbVie (ABBV) $522B. Over the last year, with dividends, A moved +15.7% and ABBV +30.3%. The P/E is 34.3 for A and 50.7 for ABBV. Dividend yield: A 0.59%, ABBV 2.35%.
At a glance
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
A$49.3B
ABBV$522B
ABBV is 11 times A
Revenue, 12 months
A$7.4B
ABBV$66.0B
ABBV is 9.0 times A
Net income, 12 months
A$1.4B
ABBV$10.3B
ABBV is 7.2 times A
Operating margin
A22.2%
ABBV32.2%
10.0 points apart
ROIC
A13.7%
ABBV25.7%
12.0 points apart
P/E
A34.3
ABBV50.7
ABBV is 1.5 times A
Dividend yield
A0.6%
ABBV2.4%
1.8 points apart
5-year return
A+12.0%
ABBV+201.5%
189.5 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
The price over time
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
A+12.0%
ABBV+201.5%
| Period | AWith dividends | ABBVWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | +15.7%Price +14.8% | +30.3%Price +26.5% |
| 3 years since November 13, 2023 | +65.5%+18.3% a yearPrice +61.9% | +135.3%+33.0% a yearPrice +112.8% |
| 5 years since November 12, 2021 | +12.0%+2.3% a yearPrice +8.1% | +201.5%+24.7% a yearPrice +152.2% |
| 10 years since November 15, 2016 | +313.9%+15.3% a yearPrice +283.2% | +605.5%+21.6% a yearPrice +369.3% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
Every figure
As on each company's page. A description, not a recommendation: no one figure says which is better.
AAgilent TechnologiesABBVAbbVie
Valuation
AABBV| Price | $173.96 | $295.03 |
|---|---|---|
| Market value | $49.3B | $522B |
| Enterprise value (EV) | $51.5B | $592B |
| P/E | 34.3 | 50.7 |
| P/E, 5-year median | 32.0 | 57.0 |
| P/B | 6.7 | – |
| EV/EBIT | 31.4 | 27.9 |
| Free cash flow yield | 2.6% | 3.6% |
Results and growth
AABBV| Revenue, 12 months | $7.4B | $66.0B |
|---|---|---|
| Net income, 12 months | $1.4B | $10.3B |
| Free cash flow, 12 months | $1.3B | $18.9B |
| Earnings per share, 12 months | $5.07 | $5.81 |
| Revenue growth, year on year | 6.7% | 8.6% |
| Revenue growth a year, past | +5.4%over 5 years | +5.9%over 5 years |
| EPS growth a year, past | +14.7%over 5 years | -2.8%over 5 years |
Margins and returns on capital
AABBV| Gross margin | 53.8% | 73.7% |
|---|---|---|
| Operating margin | 22.2% | 32.2% |
| Net margin | 19.5% | 15.7% |
| ROIC | 13.7% | 25.7% |
| ROE | 20.9% | – |
Balance sheet
AABBV| Cash | $1.8B | $10.8B |
|---|---|---|
| Total debt | $4.1B | $80.9B |
| Net debt / EBITDA | 1.1 | 3.2 |
| Interest cover | 15.5× | 7.1× |
Dividends and buybacks
AABBV| Dividend yield | 0.6% | 2.4% |
|---|---|---|
| Dividend per share, 12 months | $1.02 | $6.92 |
| Dividend growth a year, past | +6.6%over 5 years | +6.6%over 5 years |
| Buyback yield | 0.9% | 0.2% |
| Shareholder yield | 1.5% | 2.5% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
Which is bigger, Agilent Technologies or AbbVie?
By market value, AbbVie ($522B) is about 10.6 times Agilent Technologies ($49.3B), at today's prices.
How did A and ABBV stock do over the last 10 years?
Since November 15, 2016, A's price moved +283.2% and ABBV's +369.3%. With dividends: A +313.9% (+15.3% a year), ABBV +605.5% (+21.6% a year). Past returns do not predict future ones.
Which pays the higher dividend, A or ABBV?
The dividend yield at today's price is 0.59% for Agilent Technologies and 2.35% for AbbVie. Over the last twelve months they paid $1.02 and $6.92 per share.
What is the P/E of A and ABBV?
At today's price, the P/E is 34.3 for A and 50.7 for ABBV. The median of the last five years was 32.0 and 57.0, which shows where each stands against its own past.
Which has the higher profit margins, Agilent Technologies or AbbVie?
Over the last twelve months, the net margin was 19.5% for Agilent Technologies and 15.7% for AbbVie, and the operating margin 22.2% and 32.2%. Revenue was $7.4B and $66.0B.
Which is the better investment, Agilent Technologies or AbbVie?
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
Other comparisons
With each of the two, and with the largest in its sector.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
US stocksThe market today, the sectors, the largest companies and the week's results.The market's sectorsThe 11 sectors side by side: returns, share of the market, median P/E and dividend.Compare stocksTwo companies side by side: price over up to ten years, with and without dividends, and every figure.US dividend stocksEach dividend's yield next to whether the company's cash covers it and whether it was ever cut.
Descriptive data from SEC filings and market prices.